logo

For the Inventor, By the Inventor

St. Louis, MO, United States of America

Ali Shilatifard

This inventor holds 2 USPTO granted patents. Top assignees: Human Genome Sciences, Inc., Oklahoma Medical Research Foundation, Other. Active years: 1999-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ali Shilatifard. Retrieved from https://idiyas.com/inventor/ali-shilatifard-5my3s87c

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:

goldMedal1 out of 676 
 
Human Genome Sciences, Inc.
 patents
silverMedal1 out of 200 
 
Oklahoma Medical Research Foundation
 patents
bronzeMedal1 out of 834,659 
Other
 patents
where one patent can have more than one assignee

Years Active: 1999-2002

Loading Chart...
2 patents (USPTO):Explore Patents
1. 6379923 - ELL2, a new member of an ELL family of RNA polymerase II elongation factors (2002-04-30),
2. 6008018 - ELL2, a new member of an ELL family of RNA polymerase II elongation (1999-12-28),

Title: The Innovations of Ali Shilatifard

Introduction

Ali Shilatifard is a prominent inventor based in St. Louis, MO (US). He has made significant contributions to the field of molecular biology, particularly in the area of RNA polymerase II elongation factors. With a total of 2 patents, his work has implications for the treatment of neoplastic disorders.

Latest Patents

Shilatifard's latest patents include ELL2, a new member of the ELL family of RNA polymerase II elongation factors. The patents disclose ELL2 polypeptides and polynucleotides, along with methods for producing these polypeptides through recombinant techniques. Additionally, the patents outline methods for utilizing ELL2 polypeptides and polynucleotides in designing protocols for treating neoplastic disorders and developing diagnostic assays for such conditions.

Career Highlights

Throughout his career, Ali Shilatifard has worked with notable organizations such as Human Genome Sciences, Inc. and the Oklahoma Medical Research Foundation. His experience in these institutions has allowed him to advance his research and contribute to significant scientific discoveries.

Collaborations

Shilatifard has collaborated with esteemed colleagues, including Joan W. Conaway and D. Roxanne Duan. These partnerships have further enriched his research endeavors and expanded the impact of his work.

Conclusion

Ali Shilatifard's innovative contributions to the field of molecular biology, particularly through his patents on ELL2, highlight his role as a key inventor in advancing medical research. His work continues to influence the development of treatments for neoplastic disorders and diagnostic methods.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…